Day One - ET (Eastern Time, GMT-05:00)
Day One - ET (Eastern Time, GMT-05:00)
- Callie Mertel - Conference Producer, Informa Connect
- Susan Stein, Patient Advocacy and Engagement Thought Leader
Sharing our practice of multiple cross functional partners with specific ownership spanning the entire patient journey.
- Jeff Doutre - Senior Director, Patient Services, Horizon
- Merritt Davis - Director, Site of Care, Amgen
As the patient support landscape continues to evolve so do the regulatory requirements and level of oversight around programs. Hear directly from government regulators in regard to top trends, focal points and priorities for patient support programs in 2023 and beyond.
- Peter Agnoletto - Compliance Officer, General Medicines and Consumer Healthcare, Sanofi
- Matt Howatt - Assistant US Attorney, U.S. Attorney’s Office for the Eastern District of Pennsylvania
- Steven Sharobem - Assistant United States Attorney, The United States Attorney’s Office for the District of Massachusetts
- Lee Cortes - Executive Assistant United States Attorney, United States Attorney’s Office, District of New Jersey
Today's patient support model is creating unnecessary burdens for patients and caregivers due to the disjointed nature of patient support programs (PSPs). By shifting to a more integrated approach, pharma can develop a 360-degree view of the patient and the support they actually need throughout their healthcare journey. This will lead to more intuitive and efficient programs which can achieve the goal of improving patient satisfaction, delivering a seamless experience, and, ultimately, improving outcomes. Engage in conversation around the “whole person” perspective that is critical to personalizing support based on an individual’s preferences. Learn how applying a human-centric lens to your design can optimize your PSPs so they can provide help to the broader context of your patients’ lives, not just their medical conditions.
- Jenn Millard - Vice President & General Manager, U.S Integrated Patient Support, IQVIA
Patient engagement, and interactivity amongst stakeholders, is a constantly evolving model. In an age where innovation is being heavily pursued, review the unique challenges, such as health literacy and communication, in engaging with patients and identify innovative solutions to address such challenges. Understand the correlation, and inextricable link, between your patient support offerings and patient engagement.
- Susan Stein, Patient Advocacy and Engagement Thought Leader
- Marianne Gandee - Vice President, Patient Solutions & Alliances, Pfizer
Three manufacturer thought leaders with extensive experience in patient support are sharing their thoughts in a panel setting on how they use data and program insights to optimize their patient and HCP experience. The panel discussion will be complemented with sharing of best-in-class manufacturer programs in the industry and why they are considered better than other programs using insights provided by over 8,000 patients, physicians, and physician support staff. The panel discussion and best-in-class sharing will showcase how you can continue to improve your program and better meet the customer needs.
- Edward Gajewski - Principal, Nuvera Life Science Consulting
- Derek Cothran - Principal, Nuvera Life Science Consulting
- Jens Kulstad - Manager, Nuvera Life Science Consulting
- Chad Bower - Executive Director, Oncology Market Access, Daiichi Sankyo, Inc
- Jeff Park - Senior Director, Patient Support Services, Cytokinetics
- Natasha Ammenheuser - Director, Patient Access Solutions, Immunology and Dermatology, Boehringer Ingelheim
- Jenna Phillips - Head of Life Sciences Sales, Authenticx
- Amy Brown - CEO and Founder, Authenticx
- Kinshuk Saxena, PharmD, MBA - Lead, Commercialization Strategy, Novartis
- Rachael Cohn - Director, Patient and Specialty Services (NPS) Strategic Market Investments, Novartis
- Dave MacLeod - Managing Director, Value and Access, Syneos Health Consulting